Global Immunoprecipitation Testing Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Immunoprecipitation Testing Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Immunoprecipitation (IP) is the small-scale affinity purification of antigens using a specific antibody that is immobilized to a solid support such as magnetic particles or agarose resin. Immunoprecipitation is one of the most widely used methods for isolation of proteins and other biomolecules from cell or tissue lysates for the purpose of subsequent detection by western blotting and other assay techniques.
Immunoprecipitation Testing report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Immunoprecipitation Testing market is projected to reach US$ 772.5 million in 2034, increasing from US$ 528.7 million in 2022, with the CAGR of 5.5% during the period of 2024 to 2034. Demand from Academic & Research Institutes and Pharmaceutical Companies are the major drivers for the industry.
The classification of Immunoprecipitation Testing includes Individual Protein Immunoprecipitation, Co-Immunoprecipitation (Co-IP), Chromatin Immunoprecipitation (ChIP), RNA Immunoprecipitation (RIP) and others. The proportion of Individual Protein Immunoprecipitation in 2019 is about34%, the proportion of Co-Immunoprecipitation (Co-IP) is 26% in 2019.
Immunoprecipitation Testing is widely used in Academic & Research Institutes, Pharmaceutical Companies and Contract Research Organizations. The most proportion of Immunoprecipitation Testing is Academic & Research Institutes, and the sales proportion in 2019 is 51%.
North America is the largest consumption place, with a consumption market share nearly 43% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.
Market competition is intense. Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, GenScript, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Immunoprecipitation Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Thermo Fischer Scientific
Merck
GenScript
Bio-Techne
BioLegend
Takara Bio
Abcam
Rockland Immunochemicals
Cell Signaling Technology
Geno Technology
Segment by Type
Individual Protein Immunoprecipitation
Co-Immunoprecipitation (Co-IP)
Chromatin Immunoprecipitation (ChIP)
RNA Immunoprecipitation (RIP)
Others
Academic & Research Institutes
Pharmaceutical Companies
Contract Research Organizations
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Immunoprecipitation Testing market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Immunoprecipitation Testing, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Immunoprecipitation Testing industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Immunoprecipitation Testing in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Immunoprecipitation Testing introduction, etc. Immunoprecipitation Testing Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Immunoprecipitation Testing market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Immunoprecipitation Testing report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Immunoprecipitation Testing market is projected to reach US$ 772.5 million in 2034, increasing from US$ 528.7 million in 2022, with the CAGR of 5.5% during the period of 2024 to 2034. Demand from Academic & Research Institutes and Pharmaceutical Companies are the major drivers for the industry.
The classification of Immunoprecipitation Testing includes Individual Protein Immunoprecipitation, Co-Immunoprecipitation (Co-IP), Chromatin Immunoprecipitation (ChIP), RNA Immunoprecipitation (RIP) and others. The proportion of Individual Protein Immunoprecipitation in 2019 is about34%, the proportion of Co-Immunoprecipitation (Co-IP) is 26% in 2019.
Immunoprecipitation Testing is widely used in Academic & Research Institutes, Pharmaceutical Companies and Contract Research Organizations. The most proportion of Immunoprecipitation Testing is Academic & Research Institutes, and the sales proportion in 2019 is 51%.
North America is the largest consumption place, with a consumption market share nearly 43% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.
Market competition is intense. Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, GenScript, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Immunoprecipitation Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Thermo Fischer Scientific
Merck
GenScript
Bio-Techne
BioLegend
Takara Bio
Abcam
Rockland Immunochemicals
Cell Signaling Technology
Geno Technology
Segment by Type
Individual Protein Immunoprecipitation
Co-Immunoprecipitation (Co-IP)
Chromatin Immunoprecipitation (ChIP)
RNA Immunoprecipitation (RIP)
Others
Segment by Application
Academic & Research Institutes
Pharmaceutical Companies
Contract Research Organizations
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Immunoprecipitation Testing market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Immunoprecipitation Testing, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Immunoprecipitation Testing industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Immunoprecipitation Testing in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Immunoprecipitation Testing introduction, etc. Immunoprecipitation Testing Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Immunoprecipitation Testing market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices